Safety and Efficacy of transcatheter closure of paravalvular leaks - Catheter closure of PV

Kyushu University Hospital0 个研究点目标入组 15 人开始时间: 2015年11月10日最近更新: 2023年10月17日

试验速览

暂无简介。

•Patients who, at the start of screening, meet any of the following criteria are not eligible for the study: 1) Uncorrectable coagulopathy or bleeding tendency. 2) Contraindication for emergent transfusion/antiplatelet 3) Anatomically difficult for femoral puncture 4) Severe liver dysfunction 5) Severe uncontrollable systemic or local infection 6) Known allergy or contraindication for contrast 7) Known allergy for nickel/titan/stenless steel/platinum/iridium 8) Past history of severe drug allergy 9) Patients with organic lesion with hemorrhagic risk including hemorrhagic stroke within past six months 10) Patients with possible bleeding disorder(internal malignancy, diverticulitis, colitis, subacute bacterial endocarditis, severe hypertension, uncontrolled diabetes etc) 11) Patients enrolled to other clinical study with intervention or clinical trial by medicine or device within past six months 12) Intracardiac thrombus formation 13) Patients deemed as inappropriate for participating in the study by principal investigator or subinvestigator

发起方